Osler's Research Ethics Board (REB) exists to ensure all research meets current scientific, regulatory and ethical standards. All research involving patients, physicians, staff, students (i.e., research within the institution or using institutional resources), volunteers or visitors must obtain ethical approval from the REB before research can begin.
The REB operates in compliance with the following:
- the Tri-Council Policy Statement 2 (TCPS2): Ethical Conduct for Research Involving Humans (2010);
- the International Conference on Harmonization (ICH) Good Clinical Practice (GCP) Guidelines;
- Part C, Division 5 of the Food and Drug Regulations of Health Canada; and
- the Personal Health Information Protection Act (PHIPA-Ontario 1998, updated through November 2005).
All applications to conduct research at Osler must be submitted to the REB for review and approval. View a list of current REB members.
To be considered at an upcoming REB meeting, you must submit your application package to WOHSREB@williamoslerhs.ca by the deadline noted below.
2022 REB submission deadline (by noon) | 2022 REB meeting date |
---|---|
December 29 (2021) |
January 12 |
January 26 |
February 9 |
February 23 |
March 9 |
March 30 |
April 13 |
April 27 |
May 11 |
May 25 |
June 8 |
June 29 |
July 13 |
July 27 |
August 10 |
August 31 |
September 14 |
September 28 |
October 12 |
October 26 |
November 9 |
November 30 |
December 14 |
Please note: dates may be subject to change.
To learn more, please review our frequently asked questions about the REB.
Applying for REB approval |
You must apply for REB review and approval before you conduct any research activities at Osler. To apply for REB review, you must:
When you are ready to submit your study for review, please provide:
Email your submission to WOHSREB@williamoslerhs.ca. |
REB consultation services |
The REB offers one-on-one or group ethics consultations for staff, investigators, coordinators and students prior to and throughout the ethics review process. In a consultation, the REB can provide advice on:
Please contact the REB to arrange a consultation. |
Guidance for research during COVID-19 |
The REB has planned a modified reopen of selected studies to resume research activities. This plan aligns with the approach taken by Osler and follows:
Principal investigators should review the PI attestation and agreement (PAA) - resuming research activities for requirements, considerations and required signatures. Once the conditions can be confirmed as met and all required signatures are obtained, please complete and submit the PAA form to us at WOHSREB@williamoslerhs.ca. Include in the subject line your REB number, principal investigator's name and submission type. Review periodOur REB will be operating as normal, with modified procedures as per SOP 501.002. We continue to make every effort to conduct reviews in a timely manner. There may be instances, however, in which reviews may take longer than usual. In some cases, reviews may be deferred until a later date. Clinical research studies that are part of essential clinical care and/or are related to the COVID-19 pandemic will be given priority. Further updates will be posted on this page. You can also access:
|